Emp-Activity: Empagliflozin Functional Capacity
Condition(s):Heart FailureLast Updated:January 11, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Heart FailureLast Updated:January 11, 2023Recruiting
Condition(s):End Stage Renal Disease on DialysisLast Updated:January 5, 2023Not yet recruiting
Condition(s):Heart FailureLast Updated:January 10, 2023Not yet recruiting
Condition(s):Kidney Failure, Chronic; Heart FailureLast Updated:January 17, 2023Not yet recruiting
Condition(s):Acute Heart Failure; Chronic Kidney DiseasesLast Updated:January 4, 2023Recruiting
Condition(s):Heart Failure; Heart Failure With Preserved Ejection FractionLast Updated:December 23, 2022Enrolling by invitation
Condition(s):Heart FailureLast Updated:December 9, 2021Completed
Condition(s):type1diabetesLast Updated:June 8, 2021Not yet recruiting
Condition(s):Posttransplant Diabetes MellitusLast Updated:May 7, 2019Completed
Condition(s):Non-alcoholic Fatty Liver DiseaseLast Updated:May 25, 2022Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.